Böger CA - Search Results

1

Impact of NOD2/CARD15 haplotypes on the outcome after kidney transplantation.

Krüger B, Böger CA, Schröppel B, Obed A, Hoffmann U, Murphy BT, Fischereder M, Holler E, Banas B, Krämer BK. Krüger B, et al. Among authors: boger ca. Transpl Int. 2007 Jul;20(7):600-7. doi: 10.1111/j.1432-2277.2007.00486.x. Transpl Int. 2007. PMID: 17498224 Free article.

2

Cardiovascular Risk Factor Control in 70- to 95-Year-Old Individuals: Cross-Sectional Results from the Population-Based AugUR Study.

Donhauser FJ, Zimmermann ME, Steinkirchner AB, Wiegrebe S, Dietl A, Brandl C, Burkhardt R, Gessner A, Schweda F, Bergler T, Schäffner E, Böger CA, Kronenberg F, Luchner A, Stark KJ, Heid IM. Donhauser FJ, et al. Among authors: boger ca. J Clin Med. 2023 Mar 7;12(6):2102. doi: 10.3390/jcm12062102. J Clin Med. 2023. PMID: 36983106 Free PMC article.

3

The COOPERATE trial.

Krüger B, Böger C, Stubanus M, Fischereder M, Krämer BK. Krüger B, et al. Lancet. 2003 Mar 22;361(9362):1054; author reply 1055. doi: 10.1016/S0140-6736(03)12800-0. Lancet. 2003. PMID: 12660075 No abstract available.

4

Everolimus in cardiac-transplant recipients.

Banas B, Böger C, Krämer B. Banas B, et al. N Engl J Med. 2003 Dec 4;349(23):2271-2; author reply 2271-2. doi: 10.1056/NEJM200312043492322. N Engl J Med. 2003. PMID: 14657441 No abstract available.

5

RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients.

Böger CA, Fischereder M, Deinzer M, Aslanidis C, Schmitz G, Stubanus M, Banas B, Krüger B, Riegger GA, Krämer BK. Böger CA, et al. Atherosclerosis. 2005 Nov;183(1):121-9. doi: 10.1016/j.atherosclerosis.2005.03.006. Atherosclerosis. 2005. PMID: 15899487

6

Cardiovascular risk estimates and risk factors in renal transplant recipients.

Krämer BK, Böger C, Krüger B, Marienhagen J, Pietrzyk M, Obed A, Paczek L, Mack M, Banas B. Krämer BK, et al. Transplant Proc. 2005 May;37(4):1868-70. doi: 10.1016/j.transproceed.2005.04.009. Transplant Proc. 2005. PMID: 15919488 Clinical Trial.

7

Effect of HMG-CoA-reductase inhibitors on survival in type 2 diabetes patients with end stage diabetic nephropathy.

Götz AK, Böger CA, Hirschmann C, Schmitz G, Riegger GA, Krämer BK. Götz AK, et al. Among authors: boger ca. Eur J Med Res. 2005 Apr 20;10(4):155-60. Eur J Med Res. 2005. PMID: 15946911

8

Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.

Böger CA, Götz AK, Krüger B, Hösl M, Schmitz G, Riegger GA, Krämer BK. Böger CA, et al. Eur J Med Res. 2005 Apr 20;10(4):161-8. Eur J Med Res. 2005. PMID: 15946912

9

C-reactive protein as predictor of death in end-stage diabetic nephropathy: role of peripheral arterial disease.

Böger CA, Götz A, Stubanus M, Banas B, Deinzer M, Krüger B, Holmer SR, Schmitz G, Riegger GA, Krämer BK. Böger CA, et al. Kidney Int. 2005 Jul;68(1):217-27. doi: 10.1111/j.1523-1755.2005.00396.x. Kidney Int. 2005. PMID: 15954911 Free article.

10

Pretransplant calcium levels have no predictive value for delayed graft function, long-term graft function, cardiovascular events, or graft and patient survival in renal transplantation.

Krüger B, Schnitzbauer AA, Böger CA, Hoffmann U, Banas B, Farkas S, Schlitt HJ, Obed A, Krämer BK. Krüger B, et al. Among authors: boger ca. Transplant Proc. 2006 Apr;38(3):697-700. doi: 10.1016/j.transproceed.2006.01.032. Transplant Proc. 2006. PMID: 16647448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters